CN104508486B - 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列 - Google Patents

用于确定乳癌相关疾病状态的方法和用于该方法中的阵列 Download PDF

Info

Publication number
CN104508486B
CN104508486B CN201380029458.3A CN201380029458A CN104508486B CN 104508486 B CN104508486 B CN 104508486B CN 201380029458 A CN201380029458 A CN 201380029458A CN 104508486 B CN104508486 B CN 104508486B
Authority
CN
China
Prior art keywords
breast cancer
use according
biomarkers
sample
cancer cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380029458.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104508486A (zh
Inventor
C.A.K.博雷贝克
C.L.B.温格伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Priority to CN201710403116.3A priority Critical patent/CN107782901A/zh
Publication of CN104508486A publication Critical patent/CN104508486A/zh
Application granted granted Critical
Publication of CN104508486B publication Critical patent/CN104508486B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
CN201380029458.3A 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列 Expired - Fee Related CN104508486B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710403116.3A CN107782901A (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1206323.6A GB201206323D0 (en) 2012-04-10 2012-04-10 Methods and arrays for use in the same
GB1206323.6 2012-04-10
PCT/IB2013/052858 WO2013153524A1 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201710403116.3A Division CN107782901A (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列

Publications (2)

Publication Number Publication Date
CN104508486A CN104508486A (zh) 2015-04-08
CN104508486B true CN104508486B (zh) 2019-06-04

Family

ID=46177101

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380029458.3A Expired - Fee Related CN104508486B (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列
CN201710403116.3A Pending CN107782901A (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201710403116.3A Pending CN107782901A (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列

Country Status (10)

Country Link
US (2) US20150057177A1 (cg-RX-API-DMAC7.html)
EP (1) EP2836838A4 (cg-RX-API-DMAC7.html)
JP (1) JP6470681B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140143457A (cg-RX-API-DMAC7.html)
CN (2) CN104508486B (cg-RX-API-DMAC7.html)
AU (1) AU2013248138B2 (cg-RX-API-DMAC7.html)
CA (1) CA2869696A1 (cg-RX-API-DMAC7.html)
GB (1) GB201206323D0 (cg-RX-API-DMAC7.html)
MX (1) MX2014012192A (cg-RX-API-DMAC7.html)
WO (1) WO2013153524A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CN106596494B (zh) * 2016-12-29 2019-05-10 青岛科技大学 一种基于荧光传感阵列的快速筛查早中晚期乳腺癌技术
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
CN111458512A (zh) * 2019-01-21 2020-07-28 中国科学院分子细胞科学卓越创新中心 一种动脉粥样硬化生物标志物及其用途
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
CA3206126A1 (en) * 2021-01-15 2022-07-21 Universite De Fribourg Biomarkers for breast cancer detection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005005601A2 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2008048193A2 (en) * 2006-10-20 2008-04-24 Agency For Science, Technology And Research Breast tumour grading
WO2009132909A1 (en) * 2008-04-29 2009-11-05 Siemens Healthcare Diagnostics Gmbh A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
WO2010088386A1 (en) * 2009-01-28 2010-08-05 University Of Notre Dame Du Lac Accelerated progression relapse test

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330887A (en) * 1996-01-11 2001-01-26 Corixa Corp Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
CA2450379A1 (en) * 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
KR20060013425A (ko) * 2003-05-29 2006-02-09 밀레니엄 파머슈티컬스 인코퍼레이티드 유방암의 확인, 평가, 예방 및 요법에 대한 조성물, 키트및 방법
US20080026950A1 (en) * 2004-02-24 2008-01-31 Mitsubishi Rayon Co., Ltd. Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer
JP2005270093A (ja) * 2004-02-24 2005-10-06 Nippon Medical School 乳癌の術後予後予測に関与する遺伝子
WO2006105642A1 (en) * 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
JP5196465B2 (ja) * 2007-04-24 2013-05-15 公益財団法人東京都農林水産振興財団 Ｍｍｐ遺伝子発現促進剤、および、コラーゲン分解促進剤
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
JP2010151800A (ja) * 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) * 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
AU2010321829B2 (en) * 2009-11-23 2015-07-30 Genomic Health, Inc. Methods to predict clinical outcome of cancer
JPWO2011065533A1 (ja) * 2009-11-30 2013-04-18 国立大学法人大阪大学 乳癌術前化学療法に対する感受性の判定方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005005601A2 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2008048193A2 (en) * 2006-10-20 2008-04-24 Agency For Science, Technology And Research Breast tumour grading
WO2009132909A1 (en) * 2008-04-29 2009-11-05 Siemens Healthcare Diagnostics Gmbh A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
WO2010088386A1 (en) * 2009-01-28 2010-08-05 University Of Notre Dame Du Lac Accelerated progression relapse test

Also Published As

Publication number Publication date
AU2013248138B2 (en) 2019-01-17
CA2869696A1 (en) 2013-10-17
WO2013153524A1 (en) 2013-10-17
EP2836838A4 (en) 2016-03-30
GB201206323D0 (en) 2012-05-23
US20150057177A1 (en) 2015-02-26
WO2013153524A9 (en) 2014-03-13
JP6470681B2 (ja) 2019-02-13
KR20140143457A (ko) 2014-12-16
CN107782901A (zh) 2018-03-09
JP2015519043A (ja) 2015-07-09
CN104508486A (zh) 2015-04-08
EP2836838A1 (en) 2015-02-18
US20180284120A1 (en) 2018-10-04
AU2013248138A1 (en) 2014-11-27
MX2014012192A (es) 2015-05-11

Similar Documents

Publication Publication Date Title
JP6971219B2 (ja) 横断組織切片のユーザー定義領域における複数のタンパク質の同時定量
JP6971218B2 (ja) 横断組織切片のユーザー定義領域における遺伝子発現の同時定量
CN104508486B (zh) 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列
KR102014890B1 (ko) 췌장암의 존재를 결정하기 위한 방법, 어레이 및 그의 용도
CN105917230B (zh) 用于确定胰腺癌的方法、阵列和其用途
Olsson et al. Grading breast cancer tissues using molecular portraits
JP2021165745A (ja) 方法、アレイ、およびその使用
WO2012009382A2 (en) Molecular indicators of bladder cancer prognosis and prediction of treatment response
CN105283763B (zh) 用于前列腺癌的生物标志物检测中的方法和阵列
Jain Innovations, challenges and future prospects of oncoproteomics
US20190284642A1 (en) Biomarkers for the prognosis and diagnosis of cancer
EP4314347A1 (en) Proteogenomic analysis of non-small cell lung cancer
Wang et al. Distinguishing of tumor cell-targeting peptide ligands through a color-encoding microarray
JP2019032334A (ja) 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ
Lee et al. Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer
Class et al. Patent application title: METHODS FOR DETERMINING A BREAST CANCER-ASSOCIATED DISEASE STATE AND ARRAYS FOR USE IN THE METHODS Inventors: Carl Arne Krister Borrebaeck (Lund, SE) Carl Arne Krister Borrebaeck (Lund, SE) Christer Lars Bertil Wingren (Sandby, SE)
Jain Oncoproteomics

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190604

Termination date: 20210410